Related Funds
Fund Name | Location |
Arthurian Life Sciences | England, London, United Kingdom |
Blackstone Alternative Asset Management | New York, New York, United States |
Blossom Investment | China, Shanghai |
Centre for Commercialization of Cancer Immunotherapy | Canada, Montréal, Quebec |
Chengdu Zhengjian | Chengdu, China, Sichuan |
Daxinli Touzi | Beijing, Beijing, China |
DIT Partners | France, Ile-de-France, Paris |
IITM's Rural Technology & Business Incubator | - |
Kegonsa Seed Fund | - |
Luna LLC | Colorado, Denver, United States |
Mechanics Bank | California, Richmond, United States |
Nextlaw Ventures | California, Palo Alto, United States |
OKS Group | Luxembourg, Luxembourg |
Qiqian Investment | China, Hangzhou, Zhejiang |
Summit Action | New York, New York, United States |
Synovia Capital | - |
TMC Ventures | Las Vegas, Nevada, United States |
Traversant | Arizona, Phoenix, United States |
Worldwide Wes | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
BIGPICTURE | $11M | 12 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Anipen | $14M | 17 Oct 2022 | Seongnam, Kyonggi-do, South Korea | ||
Wonderwall | $21M | 25 May 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
ThorDrive | $16M | 17 Feb 2022 | Mountain View, California, United States | ||
AUTOCRYPT | $25M | 01 Dec 2021 | South Korea, Gyeonggi-do, South Korea | ||
OGQ | $58M | 18 Nov 2021 | South Korea, Gyeonggi-do, South Korea | ||
Medical IP | $17M | 06 May 2021 | South Korea, Gangwon-do, South Korea | ||
Standigm | $44M | 05 Mar 2021 | South Korea | ||
ILIAS Biologics | $20M | 28 Sep 2020 | South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
BIGPICTURE | $11M | 12 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Anipen | $14M | 17 Oct 2022 | Seongnam, Kyonggi-do, South Korea | ||
Wonderwall | $21M | 25 May 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
ThorDrive | $16M | 17 Feb 2022 | Mountain View, California, United States | ||
AUTOCRYPT | $25M | 01 Dec 2021 | South Korea, Gyeonggi-do, South Korea | ||
OGQ | $58M | 18 Nov 2021 | South Korea, Gyeonggi-do, South Korea | ||
Medical IP | $17M | 06 May 2021 | South Korea, Gangwon-do, South Korea | ||
Standigm | $44M | 05 Mar 2021 | South Korea | ||
ILIAS Biologics | $20M | 28 Sep 2020 | South Korea |